Previous 10 | Next 10 |
Charlotte, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, an...
Tier-1 Customer to Use Akoustis’ 5 GHz and 6 GHz Tandem Wi-Fi 6E Filters for a 2X4 MU-MIMO Consumer AP Platform Secures High-Volume Wi-Fi 6E Filter Orders to Support Production Ramp in March Quarter of Calendar Year 2024 Company Reiterates Current Guidance of Record Quarter...
Number of Companies Utilizing XBAW ® Foundry Services Increases to Four Launch of Akoustis’ XBAW ® Synthesizer Software as part of Foundry Services Foundry Focused on 2 to 20 GHz in Commercial and Defense Applications Charlotte, N.C., Dec. 06, 2023...
2023-11-16 07:13:38 ET More on Akoustis Technologies Seeking Alpha’s Quant Rating on Akoustis Technologies Historical earnings data for Akoustis Technologies Financial information for Akoustis Technologies For further details see: Akoustis awarded ...
Multi-Year, Multi-Million Dollar Phase 2 Award for Development of High Frequency 2-18 GHz XBAW ® Filter Technology Award Invests in Development of Akoustis’ Single-Crystal and XP3F Filter Technologies New Materials and Device Manufacturing to Target Commercial...
Charlotte, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, an...
2023-11-13 10:26:06 ET Akoustis Technologies, Inc. (AKTS) Q1 2024 Earnings Conference Call November 13, 2023 08:00 AM ET Company Participants Tom Sepenzis - IR Jeff Shealy - Founder & CEO Ken Boller - CFO Dave Aichele - EVP of Business Development C...
2023-11-13 07:35:48 ET More on Akoustis Technologies Akoustis Technologies, Inc. (AKTS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Akoustis Technologies Historical earnings data for Akoustis Technologies Financial information for ...
Q1 Revenue Up 26% Year-Over-Year, In-Line with Prior Guidance Guiding Revenue Flat in December Quarter, then 18 to 25% Growth with Record Revenue Projected in March Quarter Growth, Cost Savings Initiatives, Chips ITC Refund Support Operating Cash Flow Breakeven <1 Year Away ...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
News, Short Squeeze, Breakout and More Instantly...
Akoustis Technologies Inc. Company Name:
AKTS Stock Symbol:
NASDAQ Market:
2024-05-28 14:15:02 ET Craig-Hallum analyst issues HOLD recommendation for AKTS on May 28, 2024 12:50PM ET. AKTS was trading at $0.216 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy, 2 - Hold, 1 ...